Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81K Sell
42
-78
-65% -$7.12K ﹤0.01% 630
2026
Q1
$12.3K Buy
120
+14
+13% +$1.58K ﹤0.01% 440
2025
Q4
$13.3K Sell
106
-22
-17% -$2.8K ﹤0.01% 399
2025
Q3
$17.2K Hold
128
0.01% 386
2025
Q2
$17.4K Buy
128
+22
+21% +$2.9K 0.01% 385
2025
Q1
$14.1K Hold
106
0.01% 387
2024
Q4
$12K Hold
106
﹤0.01% 417
2024
Q3
$12.1K Hold
106
0.01% 410
2024
Q2
$11K Hold
106
0.01% 402
2024
Q1
$12K Hold
106
0.01% 416
2023
Q4
$11.7K Buy
+106
New +$10.6K 0.01% 402

Other funds holding ABT

Tidemark's ABT Position: Q2 2026 in Review

Tidemark reduced its Abbott (ABT) stake by 65% in Q2 2026, selling an estimated $7.12K and leaving 42 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Tidemark first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.4K in Q2 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Tidemark held 42 shares of Abbott worth $3.81K as of Q2 2026.
  • Tidemark sold 78 Abbott shares in Q2 2026, an estimated $7.12K.
  • Abbott made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #630 holding.
  • Tidemark first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Abbott position peaked at $17.4K in Q2 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.